News Next-Gen Proteomics Company Nautilus Biotechnology to List on Nasdaq Through Merger with Arya Sciences Acquisition Corp IIIFebruary 8, 2021 Nautilus Biotechnology Expands Executive TeamJanuary 5, 2021 Nautilus Biotechnology Appoints Nick Nelson as Chief Business OfficerOctober 15, 2020 Nautilus Biotechnology Raises $76 Million in Series B Funding to Be the First to Quantify the Human ProteomeMay 21, 2020
